サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1763178

Dダイマー検査の世界市場

D-dimer Testing

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
Dダイマー検査の世界市場
出版日: 2025年07月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Dダイマー検査の世界市場は2030年までに20億米ドルに到達

2024年に16億米ドルと推定されるDダイマー検査の世界市場は、分析期間2024-2030年にCAGR 4.0%で成長し、2030年には20億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである試薬・消耗品は、CAGR 3.6％を記録し、分析期間終了までに13億米ドルに達すると予測されます。分析装置セグメントの成長率は、分析期間中CAGR 4.8%と推定されます。

米国市場は4億2,590万米ドルと推定、中国はCAGR 3.8％で成長予測

米国のDダイマー検査市場は、2024年には4億2,590万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを3.8%として、2030年までに3億1,790万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.7％と3.4％と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界のDダイマー検査市場- 主要動向と促進要因のまとめ

Dダイマー検査が現代のヘルスケア診断に不可欠な理由とは？

Dダイマー検査は、深部静脈血栓症（DVT）や肺塞栓症（PE）などの血液凝固障害を検出するために使用される不可欠な診断ツールです。この検査では、血栓が溶ける際に形成されるタンパク質断片であるDダイマーの存在を測定し、体内での異常な凝固活性を示します。この検査は、救急医療や臨床現場において、重篤な状態を迅速かつ効果的に除外するために重要な役割を果たします。心血管疾患や静脈血栓塞栓症（VTE）の罹患率が上昇していることから、Dダイマー検査はヘルスケアにおいてますます不可欠なものとなっており、タイムリーな介入と患者の転帰の改善を確実なものにしています。効率的で正確な診断ソリューションへの需要が高まるにつれ、Dダイマー検査の使用は世界中の病院、診断センター、検査室で拡大しています。

技術革新はどのようにDダイマー検査を向上させているか？

技術の進歩はDダイマー検査市場を変革し、診断プロセスの精度、スピード、利便性を向上させています。ポイント・オブ・ケア（POC）検査機器の革新により、救急現場での迅速なDダイマー分析が可能になり、数分で結果が得られ、より迅速な臨床判断ができるようになりました。自動化された高感度測定システムも開発され、Dダイマー測定の精度が向上し、偽陽性が最小限に抑えられています。複数のバイオマーカーを組み合わせるマルチプレックス検査プラットフォームにDダイマー検査を統合することで、特にCOVID-19関連凝固異常症のような複雑な病態を検出・管理するための診断能力がさらに向上しています。これらの技術革新は、Dダイマー検査の有効性を高めるだけでなく、様々なヘルスケア環境での採用を拡大し、市場の成長に貢献しています。

ヘルスケア施設におけるDダイマー検査の採用を促進する動向とは？

早期診断と予防医療への関心の高まりが、ヘルスケア施設におけるDダイマー検査の採用を促進しています。心血管疾患が世界の死亡原因の上位を占める中、ヘルスケアプロバイダーは血栓性疾患をスクリーニングするための迅速かつ信頼性の高い方法として、Dダイマー検査を活用するようになってきています。また、POC診断ソリューションに対する需要も市場の成長を後押ししています。これらの検査は、ヘルスケア専門家が救急治療室、集中治療室、遠隔地で評価を実施することを可能にするからです。さらに、COVID-19パンデミックの継続的な影響により、凝固検査の重要性が浮き彫りになり、ウイルスに関連する凝固障害を監視・管理するためのDダイマー検査の需要が急増しています。ヘルスケアシステムが診断能力の強化を優先しているため、この動向は今後も続くと予想されます。

Dダイマー検査市場の成長を促す要因とは？

Dダイマー検査市場の成長は、心血管疾患や血栓性疾患の有病率の上昇、POC検査技術の進歩、救急医療現場における迅速診断のニーズの拡大など、いくつかの要因によってもたらされます。糖尿病や肥満など、血栓リスクの高い慢性疾患の世界の増加が、Dダイマー検査の需要をさらに押し上げています。自動アッセイや高感度アッセイなどの技術改良により、検査の精度と効率が向上しているため、ヘルスケア施設ではこれらのシステムを診断プロトコールに組み込むことが推奨されています。さらに、COVID-19の大流行が凝固検査の重要性を高め、Dダイマー診断ソリューションへの投資を促進しています。これらの要因が相まって、Dダイマー検査市場は病院、検査室、POCの各分野で拡大を続けています。

セグメント

製品タイプ（試薬・消耗品、分析装置）;検査タイプ（臨床検査室検査、POC検査）;用途（深部静脈血栓症（DVT）、肺塞栓症（PE）、播種性血管内凝固症候群（DIC）、その他の用途）;最終用途（病院、診断センター、学術・研究機関、その他の最終用途）

調査対象企業の例

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio/Data Corporation
  • Corgenix
  • F. Hoffmann-La Roche AG
  • Helena Biosciences Europe
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMにクエリーする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16307

Global D-dimer Testing Market to Reach US$2.0 Billion by 2030

The global market for D-dimer Testing estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$425.9 Million While China is Forecast to Grow at 3.8% CAGR

The D-dimer Testing market in the U.S. is estimated at US$425.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$317.9 Million by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global D-dimer Testing Market - Key Trends & Drivers Summarized

Why Is D-dimer Testing Crucial for Modern Healthcare Diagnostics?

D-dimer testing is an essential diagnostic tool used to detect blood clotting disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This test measures the presence of D-dimer, a protein fragment that forms when a blood clot dissolves, indicating abnormal clotting activity within the body. It plays a critical role in the emergency and clinical settings, as it helps rule out serious conditions quickly and effectively. Given the rising incidence of cardiovascular diseases and venous thromboembolism (VTE), D-dimer testing has become increasingly vital in healthcare, ensuring timely intervention and improved patient outcomes. As the demand for efficient and accurate diagnostic solutions grows, the use of D-dimer tests is expanding across hospitals, diagnostic centers, and laboratories worldwide.

How Are Technological Innovations Enhancing D-dimer Testing?

Technological advancements are transforming the D-dimer testing market, improving the accuracy, speed, and convenience of diagnostic processes. Innovations in point-of-care (POC) testing devices now allow for rapid D-dimer analysis in emergency settings, providing results in minutes and enabling quicker clinical decisions. Automated and high-sensitivity assay systems have also been developed, enhancing the precision of D-dimer measurements and minimizing false positives. Integration of D-dimer testing into multiplex testing platforms that combine multiple biomarkers is further enhancing diagnostic capabilities, particularly for detecting and managing complex conditions like COVID-19-related coagulopathies. These innovations are not only increasing the effectiveness of D-dimer testing but are also expanding its adoption across various healthcare settings, contributing to market growth.

What Trends Are Driving the Adoption of D-dimer Testing in Healthcare Facilities?

The increased focus on early diagnosis and preventive care is driving the adoption of D-dimer testing in healthcare facilities. With cardiovascular diseases remaining a leading cause of mortality globally, healthcare providers are increasingly utilizing D-dimer tests as a quick and reliable method to screen for thrombotic disorders. The demand for POC diagnostic solutions is also boosting market growth, as these tests enable healthcare professionals to conduct assessments in emergency rooms, intensive care units, and remote locations. Furthermore, the ongoing impact of the COVID-19 pandemic has highlighted the importance of coagulation testing, leading to a surge in demand for D-dimer tests to monitor and manage coagulopathies associated with the virus. This trend is expected to continue as healthcare systems prioritize enhanced diagnostic capabilities.

What Factors Are Driving Growth in the D-dimer Testing Market?

The growth in the D-dimer testing market is driven by several factors, including the rising prevalence of cardiovascular and thrombotic diseases, advancements in POC testing technology, and the expanding need for quick diagnostics in emergency care settings. The global increase in chronic conditions such as diabetes and obesity, which are associated with higher risks of blood clots, is further boosting the demand for D-dimer tests. Technological improvements, such as automated and high-sensitivity assays, are enhancing test accuracy and efficiency, encouraging healthcare facilities to integrate these systems into their diagnostic protocols. Additionally, the impact of the COVID-19 pandemic has elevated the importance of coagulation testing, driving investments in D-dimer diagnostic solutions. The combination of these factors is fueling the expansion of the D-dimer testing market across hospitals, laboratories, and POC settings.

SCOPE OF STUDY:

The report analyzes the D-dimer Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Consumables, Analyzers); Test Type (Clinical Laboratory Tests, Point-of-Care Tests); Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications); End-Use (Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio/Data Corporation
  • Corgenix
  • F. Hoffmann-La Roche AG
  • Helena Biosciences Europe
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • D-dimer Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular and Venous Thromboembolism (VTE) Cases
    • Increasing Use of D-dimer Testing in Point-of-Care Settings
    • Growth in Demand for High-Sensitivity D-dimer Assays
    • Technological Advancements in Rapid and Automated D-dimer Testing Devices
    • Rising Adoption of D-dimer Testing in Emergency and Clinical Settings
    • Increasing Focus on Preventive Healthcare and Early Diagnosis
    • Expansion of Telemedicine Services Supporting Remote D-dimer Testing
    • Integration of D-dimer Testing in Multiplex and Comprehensive Test Panels
    • Surge in Demand for Home-Based and Self-Monitoring D-dimer Kits
    • Growth of Diagnostic Laboratories and Testing Facilities Offering D-dimer Services
    • Rising Use of D-dimer Testing for COVID-19-Related Coagulopathy Assessment
    • Increasing Collaboration Between Diagnostic Companies and Healthcare Providers
    • Growth of Healthcare Infrastructure in Emerging Markets Expanding D-dimer Access
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World D-dimer Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for D-dimer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for D-dimer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for D-dimer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinical Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Clinical Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Clinical Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Point-of-Care Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Point-of-Care Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Point-of-Care Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Deep Vein Thrombosis (DVT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Deep Vein Thrombosis (DVT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Deep Vein Thrombosis (DVT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pulmonary Embolism (PE) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pulmonary Embolism (PE) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pulmonary Embolism (PE) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Disseminated Intravascular Coagulation (DIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Disseminated Intravascular Coagulation (DIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Disseminated Intravascular Coagulation (DIC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for D-dimer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for D-dimer Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • D-dimer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 176: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Product - Reagents & Consumables and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of World Historic Review for D-dimer Testing by Product - Reagents & Consumables and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of World 15-Year Perspective for D-dimer Testing by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of World Historic Review for D-dimer Testing by Test Type - Clinical Laboratory Tests and Point-of-Care Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of World 15-Year Perspective for D-dimer Testing by Test Type - Percentage Breakdown of Value Sales for Clinical Laboratory Tests and Point-of-Care Tests for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of World Historic Review for D-dimer Testing by Application - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of World 15-Year Perspective for D-dimer Testing by Application - Percentage Breakdown of Value Sales for Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC) and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for D-dimer Testing by End-Use - Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of World 15-Year Perspective for D-dimer Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION